Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Real Life Analysis of Brentuximab Vedotin (BV) Use As Consolidation Therapy in Patients with Hodgkin's Lymphoma (HL) with High Risk of Relapse after Autologous Stem Cell Transplantation (ASCT). a Retrospective Analysis of the EBMT Lymphoma Working Party

Blood (2022) 140 (Supplement 1): 6558–6560.

https://doi.org/10.1182/blood-2022-167644

Published: 2022

Journal Articles

Haploidentical Donor Vs. Mismatch Unrelated Donor in Reduced Intensity Conditioning Transplant: A Study from the Spanish Group of Hematopoietic Transplant and Cell Therapy (GETH-TC)

Blood (2022) 140 (Supplement 1): 7631–7633.

https://doi.org/10.1182/blood-2022-167747

Published: 2022

Journal Articles

Post-Transplant Cyclophosphamide after HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of Geth-TC

Blood (2021) 138 (Supplement 1): 3913.

https://doi.org/10.1182/blood-2021-150835

Published: 2021

Journal Articles

Identification of Circulating microRNA Signatures As Potential Noninvasive Biomarkers for Prediction to Response to Extracorporeal Photoapheresis in Patients with Graft Versus Host Disease

Raul Teruel Montoya, PhD, Oriana López-Godino, MD PhD, Nuria Garcia-Barbera, Rosa Cifuentes-Riquelme, Maria Sola, MD, Inmaculada Heras, MD PhD, Cesare Perotti, PhD MD, Vicente Vicente Garcia, MD PhD, Rocio González-Conejero, PhD, Claudia Del Fante, MD PhD, Constantino Martínez, PhD, Maria Luisa Lozano, MD PhD

Blood (2019) 134 (Supplement_1): 4466.

https://doi.org/10.1182/blood-2019-121655

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Lymphomas: Improved Results Overtime

Blood (2019) 134 (Supplement_1): 3325.

https://doi.org/10.1182/blood-2019-126507

Published: 2019

Journal Articles

Nivolumab for Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO)

Carmen Martinez, MD PhD, Cecilia Carpio, MD, Inmaculada Heras, Eduardo Ríos Herranz, MD, Joan Buch, Antonio Gutierrez, MD PhD, Samuel Romero, Izaskun Ceberio, Irene Garcia-Garcia, Antonia Rodriguez Izquierdo, PhD, Rosalia Alonso, Joan Bargay, MD PhD, Cristina Barrenetxea Lekue, PhD, Narvaez Javier, Manuel Espeso de Haro, MD, Luis Palomera, MD PhD, Ramon García-Sanz, MD PhD

Blood (2018) 132 (Supplement 1): 2936.

https://doi.org/10.1182/blood-2018-99-115774

Published: 2018

Journal Articles

CCR6, IL7R, FAS and Madcam-1 Single Nucleotide Polymorphisms Are Associated with Higher Incidence of Infections in Allogeneic Stem-Cell Transplant from a Related Donor after a Reduced Intensity Conditioning Regimen: A Multicenter Experience

Blood (2017) 130 (Supplement 1): 3208.

https://doi.org/10.1182/blood.V130.Suppl_1.3208.3208

Published: 2017

Journal Articles

Response to Proteosome Inhibitors and Immunomodulatory Drugs before and after Allogeneic Transplantation in Patients with Multiple Myeloma: A Long Term Follow up Study

Blood (2016) 128 (22): 3436.

https://doi.org/10.1182/blood.V128.22.3436.3436

Published: 2016

Journal Articles

Myeloablative Conditioning Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PTCy) As GvHD Prophylaxis in High Risk Leukemias/Myelosdysplastic Syndromes (MDS): Geth Experience

Blood (2016) 128 (22): 4690.

https://doi.org/10.1182/blood.V128.22.4690.4690

Published: 2016

Journal Articles

Influence of CD34+ and CD3+ Graft Content on Gvhd Development after Haploidentical Allogeneic Transplantation with Post-Transplant Cyclophosphamide

Mariana Bastos-Oreiro, MD, Pascual Balsalobre, PhD, Diana Champ, MD, Juan Churruca, MD, Maria Jesus Pascual, MD, Pilar Herrera, MD, Leyre Bento, MD, Jose Luis Piñana, MD, Santiago Jimenez, MD, Karem Humala, MD, Pau Montesinos, MD, Inmaculada Heras, MD, Almudena Iglesias, MD, Ana Perez-Corral, MD, Cristina Pascual, MD, Carolina Martinez-Laperche, PhD, Mi Kwon, MD, Jorge Gayoso, MD, Jose L. Diez-Martin, MD PhD

Blood (2015) 126 (23): 3131.

https://doi.org/10.1182/blood.V126.23.3131.3131

Published: 2015

Journal Articles

Persistent Cytotoxic T Lymphocyte Expansions after Allogeneic Hematopoietic Stem Cell Transplantation: Kinetics, Clinical Impact and Absence of STAT3 Mutations

Julia Muñoz-Ballester, Tzu Hua Chen-Liang, Ana María Hurtado, Pastora Iniesta, María Dolores García-Malo, José Bartolomé Nieto, José Padilla, Raul Teruel Montoya, PhD, Maria del Mar Osma, María Luisa Lozano, Felipe de Arriba, MDPhD, Francisco José Ortuño, Inmaculada Heras, MD, Vicente Vicente, Cristina Castilla-Llorente, Andres Jerez

Blood (2015) 126 (23): 3153.

https://doi.org/10.1182/blood.V126.23.3153.3153

Published: 2015

Journal Articles

Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With Reduced Intensity Conditioning (RIC) Regimens and High Dose Cylophosphamide Post-Transplant (HD-CY) As Gvhd Prophylaxis In Patients With Relapsed Or Refractory Hodgkin´s Disease: Multicentric Spanish Experience

Jorge Gayoso, MD, Pascual Balsalobre, MSc, Cristina Castilla-Llorente, MD, María Jesús Pascual, MD, Mi Kwon, MD, David Serrano, MD, Dolores Caballero, MD, PhD, Jose Antonio Pérez-Simón, Arancha Bermudez, MD, Carmen Martínez, MD, Cristina Pascual, MD, Inmaculada Heras, Carlos Solano, Angela Figuera, MD, Antonia Sampol, MD, PhD, Christelle Ferra, MD, Pilar Herrera, Ismael Buno, PhD, Jose Luis Diez-Martin, MD, PhD

Blood (2013) 122 (21): 3406.

https://doi.org/10.1182/blood.V122.21.3406.3406

Published: 2013

Journal Articles

Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With High Dose Cyclophosphamide Post-Transplant (HD-CY) As Gvhd Prophylaxis In High Risk Hematologic Malignancies: Multicentric Spanish Experience

Blood (2013) 122 (21): 2173.

https://doi.org/10.1182/blood.V122.21.2173.2173

Published: 2013

Journal Articles

Prognostic Impact of the Levels of Expression of Cell Surface Proteins Commonly Expressed by Blasts and Hematopoietic Precursor Cells in De Novo AML Patients: A Report From the Spanish Cetlam Study Group

Blood (2012) 120 (21): 1452.

https://doi.org/10.1182/blood.V120.21.1452.1452

Published: 2012

Journal Articles

WT1 Levels At Diagnosis and POST-Induction Provide Prognostic Information in Adult De Novo AML. Results From the Spanish Cetlam Group.

Josep F Nomdedeu, MD, Montserrat Hoyos, Maite Carricondo, Elena Bussaglia, PhD, Camino Estivill, Jordi Esteve, MD, PhD, Mar Tormo, Rafael F Duarte, MD, PhD, Olga Salamero, MD, PAZ Queipo De Llano, MD, Joan Bargay, Inmaculada Heras, Josep M Marti-Tutusaus, Andreu Llorente, Josep-Maria Ribera, MD, PhD, David Gallardo, MD, PhD, Anna Aventin, MD, Salut Brunet, Jorge Sierra, MD

Blood (2012) 120 (21): 2524.

https://doi.org/10.1182/blood.V120.21.2524.2524

Published: 2012

Journal Articles

Haploidentical Transplantation (HAPLO) with Post-Transplant High-Dose Cyclophosphamide for Graft Vs Host Disease (GVHD) Prevention in the Treatment of High Risk Hematological Neoplasms

Jorge Gayoso, MD, Mi Kwon, MD, David Serrano, MD, Pascual Balsalobre, MSc, Javier Anguita, MD, Cristina Pascual, MD, Ana Pérez-Corral, MD, Ismael Buno, PhD, Carolina Martinez-Laperche, PhD, Cristina Castilla-Llorente, Inmaculada Heras, Maria Jesus Pascual, Dolores Caballero, MD, Jose Luis Diez-Martin, PhD

Blood (2012) 120 (21): 4545.

https://doi.org/10.1182/blood.V120.21.4545.4545

Published: 2012

Journal Articles

The Combination of Siromilus Plus Tacrolimus (SiTac) Improves the Results of Cyclosporine Plus Mycophenolate Mofetil (CsAMMF) After Reduced Intensity Conditioning (RIC) Unrelated Donor Allogeneic Transplantation

Jose Antonio Perez-Simón, Sr., MD, PhD, Rodrigo Martino, MD, PhD, Rocio Parody, MD, M. Cabrero, Lucía López-Corral, David Valcarcel, MD, Carmen Martinez, MD, Carlos Solano, Rafael De La Camara, MD, Inmaculada Heras, Dolores Caballero, MD, Jordi Sierra, MD, PhD

Blood (2011) 118 (21): 890.

https://doi.org/10.1182/blood.V118.21.890.890

Published: 2011

Journal Articles

CXCR4 allelic Variations Influence Hematological Recovery Following Autologous Stem Cell Transplantation,

María L. Lozano, Elkin A. Niño, Juan Jose Cerezo, Cristina Castilla-Llorente, Ana I. Anton, Jose Padilla, Inmaculada Heras, Vicente Garcia

Blood (2011) 118 (21): 4098.

https://doi.org/10.1182/blood.V118.21.4098.4098

Published: 2011

Journal Articles

Graft-Failure After Allogeneic Stem Cell Transplantation. Outcome and Prognostic Factors in 80 Patients

Christelle Ferrà, Jaime Sanz, MD, Miguel-Angel Díaz-Pérez, Mireia Morgades, Jorge Gayoso, José-Rafael Cabrera, María-Teresa Villaescusa, Guillermo Sanz, MD, Francesc Fernández-Avilés, Carlos Solano, Rafael F. Duarte, MD, PhD, Miguel Ortin, Inmaculada Heras, Moraleda José-María, Javier De la Serna, MD, PhD, Barrenetxea Cristina, Josep-Maria Ribera, MD, PhD

Blood (2011) 118 (21): 1936.

https://doi.org/10.1182/blood.V118.21.1936.1936

Published: 2011

Journal Articles

Phase I/I Clinical Trial for the Evaluation of Bortezomib within the Reduced Intensity Conditioning Regimen (RIC) and Post-Allogeneic Transplantation As Gvhd Prophylaxis Among High-Risk Myeloma Patients. EudraCT: 2005–004858-27

Jose Antonio Perez-Simón, Sr., MD, PhD, Teresa Caballero-Velazquez, Cristina Encinas, Cristina Castilla-Llorente, Rodrigo Martino, MD, PhD, Laura Rosiñol, MD, Antonia Sampol, MD, Dolores Caballero, MD, David Serrano, Inmaculada Heras, Jesus F San Miguel

Blood (2011) 118 (21): 3025.

https://doi.org/10.1182/blood.V118.21.3025.3025

Published: 2011

NARROW

Real Life Analysis of Brentuximab Vedotin (BV) Use As Consolidation Therapy in Patients with Hodgkin's Lymphoma (HL) with High Risk of Relapse after Autologous Stem Cell Transplantation (ASCT). a Retrospective Analysis of the EBMT Lymphoma Working Party

Haploidentical Donor Vs. Mismatch Unrelated Donor in Reduced Intensity Conditioning Transplant: A Study from the Spanish Group of Hematopoietic Transplant and Cell Therapy (GETH-TC)

Post-Transplant Cyclophosphamide after HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of Geth-TC

Identification of Circulating microRNA Signatures As Potential Noninvasive Biomarkers for Prediction to Response to Extracorporeal Photoapheresis in Patients with Graft Versus Host Disease

Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Lymphomas: Improved Results Overtime

Nivolumab for Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO)

CCR6, IL7R, FAS and Madcam-1 Single Nucleotide Polymorphisms Are Associated with Higher Incidence of Infections in Allogeneic Stem-Cell Transplant from a Related Donor after a Reduced Intensity Conditioning Regimen: A Multicenter Experience

Response to Proteosome Inhibitors and Immunomodulatory Drugs before and after Allogeneic Transplantation in Patients with Multiple Myeloma: A Long Term Follow up Study

Myeloablative Conditioning Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PTCy) As GvHD Prophylaxis in High Risk Leukemias/Myelosdysplastic Syndromes (MDS): Geth Experience

Influence of CD34+ and CD3+ Graft Content on Gvhd Development after Haploidentical Allogeneic Transplantation with Post-Transplant Cyclophosphamide

Persistent Cytotoxic T Lymphocyte Expansions after Allogeneic Hematopoietic Stem Cell Transplantation: Kinetics, Clinical Impact and Absence of STAT3 Mutations

Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With Reduced Intensity Conditioning (RIC) Regimens and High Dose Cylophosphamide Post-Transplant (HD-CY) As Gvhd Prophylaxis In Patients With Relapsed Or Refractory Hodgkin´s Disease: Multicentric Spanish Experience

Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With High Dose Cyclophosphamide Post-Transplant (HD-CY) As Gvhd Prophylaxis In High Risk Hematologic Malignancies: Multicentric Spanish Experience

Prognostic Impact of the Levels of Expression of Cell Surface Proteins Commonly Expressed by Blasts and Hematopoietic Precursor Cells in De Novo AML Patients: A Report From the Spanish Cetlam Study Group

WT1 Levels At Diagnosis and POST-Induction Provide Prognostic Information in Adult De Novo AML. Results From the Spanish Cetlam Group.

Haploidentical Transplantation (HAPLO) with Post-Transplant High-Dose Cyclophosphamide for Graft Vs Host Disease (GVHD) Prevention in the Treatment of High Risk Hematological Neoplasms

The Combination of Siromilus Plus Tacrolimus (SiTac) Improves the Results of Cyclosporine Plus Mycophenolate Mofetil (CsAMMF) After Reduced Intensity Conditioning (RIC) Unrelated Donor Allogeneic Transplantation

CXCR4 allelic Variations Influence Hematological Recovery Following Autologous Stem Cell Transplantation,

Graft-Failure After Allogeneic Stem Cell Transplantation. Outcome and Prognostic Factors in 80 Patients

Phase I/I Clinical Trial for the Evaluation of Bortezomib within the Reduced Intensity Conditioning Regimen (RIC) and Post-Allogeneic Transplantation As Gvhd Prophylaxis Among High-Risk Myeloma Patients. EudraCT: 2005–004858-27

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only